U S PHYSICAL THERAPY INC /NV (USPH): Results of Operations and Financial Condition
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 ex99-1.htm Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results,
How this was made
The 30-second read
Why it matters
The key tradable elements are the reported Q2/YTD operating metrics, the stated integration milestone (31 clinics completed, 39 expected in Q3), and management’s expectation for accelerating adjusted EBITDA improvement in 2H 2026 and into 2027.
Market read
This is a company-specific earnings-style update with operational KPIs and a stated execution timeline for hospital-affiliated clinic integrations, which can drive revisions to 2H 2026 and 2027 expectations.
What to watch
GAAP net income and EPS fell year over year, and cash declined while debt increased; traders may focus on leverage and liquidity alongside operating KPIs.
Background
U.S. Physical Therapy, Inc. filed an 8-K with its Q2 2026 operating results and commentary on integrating hospital-affiliated clinics and operational initiatives.
Ticker impact
USPH reported Q2 2026 results and reaffirmed full-year guidance, including integration progress of 31 hospital-affiliated clinics and updated margin drivers.
Near-term trading likely hinges on whether investors view the margin compression and GAAP EPS decline as temporary versus the credibility of the 2H 2026 adjusted EBITDA acceleration plan.
The filing provides multiple operating KPIs (revenue, visits, revenue per visit, margins) plus balance-sheet and capital allocation updates, but it does not include explicit new full-year numeric guidance in the provided excerpt.
Market effects
Outpatient therapy operators may see read-through on demand durability (patient visits growth) and margin sensitivity to health benefit costs.
No specific regional catalyst beyond nationwide clinic integration execution.
Limited global relevance; primarily a US healthcare services operator update.
Counterpoint
Investors may discount the 2H 2026 adjusted EBITDA acceleration if the Q2 margin decline from health benefit costs signals structural cost pressure rather than a one-off timing issue.
Key entities
- public_companyU.S. Physical Therapy, Inc.
NYSE-listed outpatient physical therapy operator reporting Q2 2026 results and reaffirming full-year guidance.
- executiveJason Curtis
Interim CFO referenced in the filing contact block.
- executiveChris Reading
CEO/Chairman quoted on integration progress and 2H 2026 adjusted EBITDA expectations.
